This Editorial discusses a Health Economics and Outcomes Research (HEOR) approach to use a formal comparative effectiveness analysis and a network meta-analysis for both first- and second-line ART regimens for adults, adolescents and children.
Browsing: Viral > HIV / AIDS
Given the ability of the microbiota to instruct the immune system and control the inflammatory response, the authors discuss the potential of targeting the microbiota to improve the immune recovery and dampen inflammation during HIV infection.
Researchers have applied concepts from financial mathematical models to help predict the evolution of HIV proteins with the hope this could improve vaccine design.
This opinion piece discusses the many challenges inherent in caring for HIV+ individuals with new-onset seizure. With more questions than answers in both resource-limited settings and more developed medical environments what do we need to elucidate going forwards?
A new mathematical model suggests that the development of a vaccine against HIV, even if it is only partially effective, could be hugely important for the elimination of HIV worldwide.
Researchers looking at the genome of M. tuberculosis have discovered that HIV co-infection could be influencing how the bacteria are evolving.
Researchers have demonstrated that MRI scans could help to diagnose patients with cognitive problems due to HIV-related inflammation, presenting an alternative to lumbar punctures.
Even in the era of antiretroviral treatment, mucosal candidiasis remains one of the most common manifestations in HIV-infected subjects. This editorial discusses the loss of immune control that allows mucosal candidiasis to occur.